Pharmaceutical Technology

JULY 26, 2022

The last few months have marked the publication of research emerging from projects designed to collect and analyse genomic data on a wider scale than was previously thought possible. The post Magazine: Genomic projects exploit scale as clinical applications play catch-up appeared first on Pharmaceutical Technology.

Genome Project 130

Genome Project Genome Genomics Clinical Trials 130

pharmaphorum

SEPTEMBER 14, 2020

Here he gives us a deeper look at how genomic medicine is evolving and the barriers that are preventing it from reaching its full potential. I saw this, in particular, with the finishing of the human genome,” says Charlie. “At In reality, finishing the human genome was the first step of what is a long journey.”.

Genome 119

Genome Genomics Medicine Gene 119

pharmaphorum

MARCH 25, 2021

The COSMIC (Catalogue of Somatic Mutations in Cancer) database, operated by the Wellcome Sanger Institute, grew out of the work of the Cancer Genome Project and has been gathering data on mutations associated with specific cancers for almost 17 years. The post COSMIC database matches drugs to cancer mutations appeared first on.

Drugs 59

Drugs Genome Project Genome Genomics 59

pharmaphorum

FEBRUARY 26, 2021

Small sample size in trials: Finding eligible patients for clinical trials of orphan medicines is a big challenge. For instance, the UK government’s 100K Genomes Project has achieved its goal of sequencing the genomes of 100,000 people in 2019.

Drugs 78

Drugs Genome Project Genome Genomics 78

XTalks

NOVEMBER 3, 2023

CRISPR works as genetic scissors to edit parts of the genome. The companies used data from the 1,000 Genomes Project but from that, only 61 datasets made the cut to encompass the ideal patient population. “I The CRISPR-Cas9 gene editing system was first discovered to be endogenous in bacteria.

Gene Therapy 59

Gene Therapy Gene Gene Editing In-Vivo 59

The Pharma Data

APRIL 6, 2021

The data include an oral presentation in a Clinical Trials Plenary Session on April 10 on the Phase III trial CHRONOS-3 evaluating copanlisib (Aliqopa ) in combination with rituximab in patients with relapsed indolent non-Hodgkin’s Lymphoma (iNHL). o Abstract 394; April 10, 8:30am EDT. o Abstract 1008; April 10, 8:30am EDT.

Research 52

Research Genome Project Gene Genome 52

pharmaphorum

APRIL 20, 2022

As a result, the advancement in genetic sequencing, powered by programs such as The Cancer Genome Atlas and the 100,000 Genomes Project, has led to a greater understanding of the genes that have direct implications in the causes of cancer.

Gene Editing 52

Gene Editing DNA Gene Genetics 52